Published • loading... • Updated
Ekuinas acquires strategic minority stake in Malaysia's pharmaceutical firm Ain Medicare
Summary by TechNode Global
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Ekuinas acquires strategic minority stake in Malaysia's pharmaceutical firm Ain Medicare
Ekuiti Nasional Berhad (Ekuinas) announced Tuesday its investment in Ain Medicare Sdn Bhd, a Bumiputera home-grown manufacturer of sterile parenteral pharmaceutical products. Ekuinas said in a statement that the investment, made via Ekuinas’ MYR 1 billion ($790 million) Tranche IV fund, will see Ekuinas acquire a strategic minority shareholding in the company. This aligns with Ekuinas’ mandate to scale Bumiputera enterprises operating in strateg…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
